The Latin America animal health market size accounted for USD 7.2 billion in 2025 and is predicted to increase from USD 7.86 billion in 2026 to approximately USD 17.33 billion by 2035, expanding at a CAGR of 9.18% from 2026 to 2035. Animal health is the most significant factor for the farmer to address, given that poor animal health has fast economic impacts on the agriculturalist, which drives the growth of the market.
Animal health is the maintenance of animals’ physical health to ensure their welfare and food production. This means controlling challenges and handling the impact of transboundary and zoonotic diseases, since both affect productivity and jeopardise the stability of ecosystems, human health, and food safety. Animals are a significant source of food for humans, but they are not healthy; the food they offer will not be as healthy. Animals play a significant role in the ecosystem, and if they are not strong, it throws off the balance of nature. Their health is significant for research purposes, as major medical breakthroughs have been made possible by researching sick animals. Animal health is significant to the economy for various reasons.
Recent advancements in gene editing technologies, integrated with molecular breeding, have enabled scientists to effectively develop livestock with improved disease resistance through targeting particular disease-associated genes. Genomics editing is the advance breeding tool that allows for accelerating the rate of genetic enhancement for health and well-being traits in food animals. It allows the introduction of advanced alleles in a single generation, involving those that are of low frequency, while efficiently bypassing linkage drag. This editing technology provides the strength to target and alter genes in particular ways. These technologies play a significant role in food and farming systems.
By product type, the pharmaceuticals segment contributed the largest Latin America animal health market share of 41% in 2025, as animal pharmaceuticals are treatments that are intended to prevent, diagnose, or manage disease in animals to enhance overall welfare. Pharmaceuticals for veterinary medicine aid in the defence of animal health, food security, and public well-being. Veterinary pharmaceutical products perform major tasks, from preventing diseases to handling chronic conditions, which is advantageous for both animals and humans.
By animal type, the livestock animals segment contributed the largest Latin America animal health market share of 57%, as livestock contributes to the biosphere's supply of protein and energy and produces nutrient-rich food products. The field offers livelihoods for over a billion individuals worldwide, providing a economical safety net and stable income, specifically in rural and developing areas.
By indication, the infectious diseases segment held the dominant share of 29% in the market, as the prevention and control of animal infectious diseases is expected to have a positive impact, both financially and in terms of food security. Infections in animals impact food manufacturing and drive antibiotic applications.
By end user, the veterinary hospitals segment contributed the largest Latin America animal health market share of 31%, as this hospital plays a significant role in offering significant veterinary services, ranging from routine check-ups and vaccinations to emergency surgeries and specialized treatments. Animal hospitals are pivotal in maintaining the health of livestock and pets. The main aim of these services is to ensure that animals obtain the maximum possible care, therefore enhancing their quality of life and longevity.
Leading companies in the Latin America animal health market include Ceva Santé Animale, Virbac, Elanco Animal Health, and Zoetis. Meanwhile, Ceva Santé Animale, a strong regional player significantly focused on poultry and ruminant vaccines in the Latin American agricultural sectors, and Virbac, which provides high-quality, efficient veterinary products and supplements for livestock, poultry, equine, companion animals, and aquaculture. Elanco Animal Health, it advance portfolio of parasiticides and vaccines, is deeply attentive to enhancing agricultural sustainability, and Zoetis, the main producer of medicine for pets and livestock, has wide dominance across South America in companion animal, swine, and cattle treatment.
By Product Type
By Animal Type
By Indication
By Route of Administration
By Distribution Channel
By Delivery Mode
By Region
